Zipantola 20 mg želučanootporne tablete
| Name | Zipantola 20 mg želučanootporne tablete |
|---|---|
| Marketing Authorisation Number | HR-H-638648222 |
| Active Substance | pantoprazolnatrij seskvihidrat |
| Composition | jedna želučanootporna tableta sadrži 20 mg pantoprazola u obliku pantoprazolnatrij seskvihidrata |
| Pharmaceutical Form | želučanootporna tableta |
| Packaging [MA Number for Packaging] | 28 tableta u blisteru, u kutiji [HR-H-638648222-01] 56 tableta u blisteru, u kutiji [HR-H-638648222-02] 28 tableta u perforiranom blisteru s jediničnim dozama, u kutiji [HR-H-638648222-03] 56 tableta u perforiranom blisteru s jediničnim dozama, u kutiji [HR-H-638648222-04] |
| Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska Teva Pharma S.L.U., Zaragoza, Španjolska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 20.07.2015 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/464 |
| Registration Number | 381-12-01/30-15-07 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | A02BC02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
